Skip to main content
MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED logo

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED — Investor Relations & Filings

Ticker · MVP ISIN · AU000000MVP2 LEI · 9845007EAECAOD1U4493 ASX Manufacturing
Open in API
Filings indexed 908 across all filing types
Latest filing 2020-08-19 Governance Information
Country AU Australia
Listing ASX MVP

About MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED

https://medicaldev.com

Medical Developments International Limited specializes in the development and distribution of emergency pain relief and respiratory products. The company's flagship product is Penthrox, a handheld, self-administered inhaler providing rapid-onset, non-opioid analgesia using methoxyflurane. Penthrox is utilized globally by emergency medical services, hospitals, and for procedural pain in various clinical settings. Additionally, the company manufactures a range of respiratory medical devices, including anti-static spacers and asthma management tools designed to optimize medication delivery. The organization focuses on providing portable, effective solutions for acute pain management and respiratory care, catering to healthcare professionals and patients in emergency, surgical, and primary care environments.

Recent filings

Filing Released Lang Actions
Corporate Governance Statement 7 pages 232.3KB
Governance Information Classification · 100% confidence The document is titled 'Medical Developments International Limited Corporate Governance Statement' dated 20 August 2020. It extensively discusses the company's corporate governance practices, board responsibilities, committees, policies on diversity, ethical conduct, financial reporting integrity, shareholder rights, and risk management. It references compliance with ASX Corporate Governance Principles and includes detailed descriptions of board structure, committees, and governance policies. There is no indication that this is an Annual Report, Audit Report, or any financial statement. It is not a notice of meeting or voting results, nor a call transcript or earnings release. The content aligns with a Governance Information report detailing the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and detailed content confirm it is a full governance report, not a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2020-08-19 English
Medical Developments to take control of EU markets 2 pages 191.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 August 2020 regarding Medical Developments International entering into an agreement to take back distribution rights for its drug in the EU. The content focuses on a business deal and operational update about distribution rights and market strategy. There is no financial report, earnings data, regulatory certification, or voting results. The document is a corporate announcement about a commercial agreement and business development, which fits best under Capital/Financing Update (CAP) as it relates to a significant contract and business restructuring impacting the company's capitalized assets and revenue streams. The document length is about 5144 characters, which is consistent with an announcement rather than a full report. Therefore, the classification is CAP with high confidence.
2020-08-18 English
Head of Europe Appointed 2 pages 181.6KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 19 August 2020 regarding the appointment of Mr. Stefaan Schatteman as Head of the European business for Medical Developments International. The content focuses on management changes and leadership appointments, with no financial data, report references, or regulatory filings mentioned. The document is approximately 4,835 characters, which is relatively short and clearly an announcement rather than a detailed report. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2020-08-18 English
Trading Halt 2 pages 212.8KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from Medical Developments International Limited regarding a trading halt requested under ASX listing rule 17.1. It states the halt is pending a major announcement about distribution of a product in the EU. The document is short (2158 characters) and does not contain financial data, results, or detailed report content. It is an announcement about a trading halt, not a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-08-17 English
Ceasing to be a substantial holder 17 pages 322.6KB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and references 'Corporations Law Section 671B' which pertains to substantial shareholder notices. It details the cessation of a substantial holder status for Bank of America Corporation and its related bodies corporate, including detailed tables of changes in relevant interests, dates, and securities affected. The content is focused on changes in shareholding and voting rights, with no financial statements, management commentary, or audit information. This matches the definition of a 'Major Shareholding Notification' which reports changes in significant share ownership levels crossing thresholds. The document length is substantial and contains detailed transactional data, confirming it is the notification itself, not an announcement of a report. Therefore, the correct classification is 'MRQ' (Major Shareholding Notification).
2020-07-29 English
Ceasing to be a substantial holder 1 page 71.0KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 Notice of ceasing to be a substantial holder under the Corporations Act 2001. It details changes in relevant interests and voting securities of a substantial holder, including dates and share transactions. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document length is short and it is not an announcement of a report publication or a certification, so it is not RPA or RNS. Therefore, the correct classification is MRQ with high confidence.
2020-07-12 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.